Speaking at the opening of the facility in Ituri province, Tedros said four patients would be discharged on Sunday, while another had left care two days earlier, highlighting signs of progress in combating the Bundibugyo strain of Ebola, a rare variant for which no approved vaccine or specific treatment currently exists.

“Of course, we’re still working on vaccines and treatments but that doesn’t mean that people cannot recover from Ebola,” Tedros said.

The announcement follows confirmation by the WHO on Friday of the first documented recovery of a patient infected with the Bundibugyo virus during the current outbreak, a development health officials hope will encourage infected individuals to seek medical attention sooner.

According to the latest official figures released by the WHO, the outbreak has generated 906 suspected cases and 223 suspected deaths in Congo. The disease has also crossed borders, with neighboring Uganda reporting nine confirmed cases and one death, according to the Ugandan Health Ministry.

Despite the opening of new facilities and the arrival of additional international assistance, humanitarian organization Doctors Without Borders, known by its French acronym MSF, warned on Saturday that the virus continues to outpace containment efforts. The group called for expanded testing capacity, faster deployment of health personnel and uninterrupted access for medical supplies.

Health authorities have faced growing operational challenges as some local communities resist strict disease-control measures, particularly protocols governing the handling and burial of Ebola victims. Officials say at least three attacks have been carried out against health centers during the outbreak.

Tedros emphasized the importance of community cooperation, urging residents to seek treatment immediately after symptoms appear and to participate actively in containment efforts.

“If you come to health facilities when you have symptoms, you can get the support and recover,” he said, adding that early intervention remains critical to improving survival rates.

Security concerns have further complicated the response. In Ituri, attacks by the Allied Democratic Forces, an armed group linked to Daesh, along with violence involving ethnic militias, have limited access to some affected communities and disrupted medical operations.

The outbreak has also been reported in the eastern provinces of North Kivu and South Kivu, where Rwanda-backed M23 rebels control several strategic urban centers, including Goma and Bukavu. The rebel movement has reported two Ebola cases in areas under its control.

Congolese health officials sought to reassure residents that the outbreak can be contained. Pierre Akilimali, incident manager at the National Institute of Public Health, said symptomatic treatment was producing encouraging results and helping patients recover.

Medical staff at the new treatment center echoed that assessment. Davin Ambitapio, a physician involved in the response, said healthcare workers remained optimistic that coordinated efforts by national authorities and international partners would eventually bring the outbreak under control.

The Bundibugyo strain was first identified in Uganda in 2007 and is one of several known Ebola virus species capable of causing severe hemorrhagic fever outbreaks in humans.

The attack occurred in Rwampara, near the epicenter of the outbreak in Ituri Province, where local youths stormed and burned parts of a treatment facility after a man believed to have died from Ebola was denied a traditional funeral, according to witnesses and police officials.

Authorities said the confrontation stemmed from public resistance to emergency burial protocols designed to prevent transmission of the highly contagious virus.

Under outbreak regulations, suspected Ebola victims must be buried by trained teams because bodies can remain infectious and contribute to further spread.Deputy Senior Commissioner Jean Claude Mukendi, head of public security in Ituri Province, said relatives and friends of the deceased attempted to take the body home despite official restrictions. Police intervened but were unable to prevent the unrest.

Witnesses reported that aid workers evacuated the facility as protesters entered the center and set fire to equipment and structures. Humanitarian organization ALIMA, which operates at the site, later said calm had been restored and medical teams had resumed their work.

The incident highlights the growing challenges facing Congolese authorities and international aid agencies as they confront an outbreak that the World Health Organization has designated a public health emergency of international concern.Health officials reported 671 suspected cases and 160 suspected deaths across two provinces as of Thursday.

The outbreak has also crossed borders, with neighboring Uganda reporting cases, including at least one death.The WHO and regional health authorities have warned that the true scale of the outbreak is likely significantly larger than official figures indicate. Surveillance efforts are continuing as investigators seek to identify additional infections and trace transmission chains.

The outbreak is centered in Ituri Province, a region affected by chronic insecurity, weak healthcare infrastructure and large-scale population displacement. More than 920,000 internally displaced people are living in the province, according to United Nations estimates, complicating disease surveillance and response efforts.

Health experts say the Bundibugyo strain responsible for the outbreak presents additional challenges because no approved vaccine or specific treatment is currently available. Officials estimate it could take at least six to nine months before a vaccine becomes available.The virus has now spread beyond Ituri and North Kivu provinces.

On Thursday, authorities reported the first confirmed cases in South Kivu Province, including a death near the city of Bukavu, approximately 500 kilometers south of the outbreak’s center.The disease circulated undetected for weeks after the first known fatality in late April, partly because initial investigations focused on more common Ebola strains previously seen in the country.

Health authorities have yet to identify the outbreak’s first infected patient.The escalating crisis has begun to affect international travel and regional events. India and the African Union announced the postponement of the India-Africa Forum Summit scheduled for next week in New Delhi, citing the evolving health situation in parts of Africa.

The United States has also imposed screening measures and travel restrictions for individuals recently arriving from affected countries.

Ebola spreads through direct contact with bodily fluids and can cause fever, vomiting, diarrhea, muscle pain and severe hemorrhagic symptoms.

Public health officials say rapid detection, isolation and community cooperation remain critical to containing the outbreak.

India’s foreign ministry said the two sides agreed to delay the summit, originally scheduled for May 28-31, citing the “emerging public health situation” across parts of Africa. The ministry said fresh dates for the gathering would be announced later.

The decision comes after the World Health Organization warned on Wednesday that the Ebola outbreak in eastern Democratic Republic of Congo posed a high regional risk, although the threat remained low globally.

The WHO said the virus had likely been circulating undetected for months before the outbreak was officially declared last week.

The latest outbreak, the 17th recorded in Congo, has already been linked to 139 suspected deaths from roughly 600 probable cases, according to health authorities. Ebola, a highly infectious hemorrhagic fever, has killed more than 15,000 people across Africa over the past five decades.

India said it stood ready to support Africa Centres for Disease Control and Prevention-led efforts aimed at containing the outbreak and strengthening public health response systems across the continent.

Delhi’s Indira Gandhi International Airport issued a health advisory on Thursday for passengers arriving from Democratic Republic of Congo as well as neighboring Uganda and South Sudan, reflecting growing concern over cross-border transmission risks.

The India-Africa Forum Summit is one of New Delhi’s key diplomatic platforms for engagement with African nations, covering trade, development cooperation, infrastructure and strategic partnerships. The postponement marks a rare disruption to the high-level forum amid heightened global vigilance over infectious disease outbreaks.

Officials said the virus likely circulated undetected for weeks because initial testing focused on more common Ebola strains. No approved vaccine currently exists for the Bundibugyo variant, with WHO estimating any targeted vaccine could take six to nine months to develop.

The outbreak is unfolding in conflict-hit areas of eastern Congo, where insecurity, population displacement and weak health infrastructure are complicating containment efforts.

The WHO said the outbreak did not yet meet the threshold for a pandemic emergency but warned that countries bordering Congo faced a heightened risk of further spread as infections expanded across eastern regions and new cases emerged in Uganda’s capital, Kampala.

According to the agency, 80 suspected deaths, eight laboratory-confirmed cases and 246 suspected infections had been reported as of Saturday in Congo’s Ituri province, particularly in the health zones of Bunia, Rwampara and Mongbwalu.

The Congolese health ministry had earlier confirmed that at least 80 people had died in the outbreak, which health officials believe may be significantly larger than currently documented because of high positivity rates in early testing and increasing numbers of suspected infections.

The outbreak involves the Bundibugyo strain of Ebola virus disease, a rarer variant for which no approved vaccines or targeted therapeutics currently exist, unlike the more common Ebola-Zaire strain that has been the focus of previous immunization campaigns in Central Africa.

The WHO described the situation as “extraordinary,” warning that international transmission had already been documented.

In Kampala, two unrelated laboratory-confirmed Ebola cases, including one death, were identified on Friday and Saturday in travelers arriving from Congo, according to the agency. A confirmed case was also detected in Kinshasa involving a traveler returning from Ituri province.

The WHO urged governments to activate national emergency-response systems, intensify border screening and strengthen surveillance along internal transportation routes to contain further spread.
The agency also advised that confirmed Ebola patients and close contacts should avoid international travel except for medical evacuation purposes.

It recommended immediate isolation of confirmed cases, daily monitoring of contacts and restrictions on domestic travel for exposed individuals until 21 days after potential infection.

At the same time, the WHO cautioned governments against shutting borders or imposing sweeping trade restrictions, warning that such measures could push movement across unofficial crossings beyond the reach of health monitoring systems.

The outbreak poses an additional challenge for regional health systems already strained by conflict, population displacement and limited medical infrastructure in eastern Congo, where previous Ebola epidemics have repeatedly tested emergency response capacities.

At Jemo Health Centre on the outskirts of Addis Ababa, health worker Tewodros Tibebu says social stigma and limited awareness continue to delay access to comprehensive abortion care, despite Ethiopia legalizing broad abortion services more than two decades ago.

Tibebu, who has worked in comprehensive abortion care for four years, is among only three trained providers currently delivering the service at the facility. According to his account, many patients arrive after significant delays, often seeking help only after complications emerge from procedures carried out elsewhere.

“The biggest challenge is stigma,” Tibebu said in a feature published by the World Health Organization on May 5. “Many women are afraid someone will recognize them when they come here. Others do not even know the service exists.”Comprehensive abortion care has reportedly been available at Jemo Health Centre for nearly a decade.

However, Tibebu said access barriers remain widespread, particularly for women seeking confidential and medically supervised treatment.According to his account, many patients first visit private clinics where procedures may be carried out by practitioners lacking formal training in abortion care. By the time some women reach public facilities such as Jemo, they are already suffering from infections or sepsis that could have been prevented through earlier medical intervention.

Ethiopia expanded legal access to abortion in 2005 under revised provisions that allowed the procedure under broader circumstances than previously permitted. Despite the legal framework, health care providers and reproductive health organizations have continued to report uneven access across regions, driven by social stigma, provider shortages and gaps in public awareness.

Tibebu said the stigma surrounding abortion services affects providers as well as patients. “Some coworkers oppose the comprehensive abortion care department,” he said. “Some people in my community do not know what I do.”The social pressures attached to abortion care are a recurring issue in reproductive health systems globally, particularly in countries where legal reforms have outpaced shifts in public attitudes or health infrastructure.

Health workers often face professional isolation, ethical scrutiny and personal criticism while providing services that remain politically and culturally contested.Tibebu said professional training helped him better understand both the clinical and ethical dimensions of abortion care. “Before, it was difficult,” he said.

“After I received specific training, I understood the work differently and could provide the care women need.”The experiences described by Tibebu formed part of a broader announcement by the Human Reproduction Programme, known as HRP, regarding a new international training initiative on comprehensive abortion care.

The programme, launched through the WHO Academy platform, combines four separate learning modules focused on medical abortion, surgical abortion, post-abortion care and human rights integration in comprehensive abortion care. According to HRP, the courses are designed to provide modular and interactive learning environments that simulate real clinical decision-making scenarios encountered by frontline health workers.

WHO said the training initiative is intended to strengthen evidence-based care and improve consistency in abortion services across different health systems. The programme also places emphasis on privacy, non-discrimination and accountability within clinical practice.

The human rights integration component links medical treatment with broader principles related to patient dignity and access to care, according to WHO. Together, the courses are intended to establish a standardized framework for providers working in comprehensive abortion care settings.The launch reflects continuing international efforts by global health organizations to reduce preventable maternal complications associated with unsafe abortion procedures.

WHO has repeatedly stated in policy guidance that access to trained providers, accurate information and safe clinical environments are central to reducing maternal morbidity and mortality.At facilities such as Jemo Health Centre, providers say the gap between legal availability and practical access remains significant.

Tibebu noted that many patients learn about the service only through informal networks and word-of-mouth referrals rather than official health campaigns or referrals from primary care systems.That reliance on informal communication channels, he said, contributes to delays that can worsen medical outcomes.

The WHO feature also highlighted the operational pressures facing providers in facilities with limited staffing. With only three trained workers handling abortion care services at Jemo, workloads remain concentrated among a small number of clinicians.

Training programmes such as the one launched by HRP are intended in part to address those shortages by expanding provider knowledge and strengthening clinical capacity. WHO said the interactive nature of the courses allows health workers to engage with practical decision points similar to those encountered during patient care.

The organization has increasingly used digital and modular learning systems to expand access to specialized medical training, particularly in lower-resource health settings where formal clinical education opportunities may be limited.Tibebu said the training reinforced his understanding of abortion care not only as a technical medical service but also as direct patient support during periods of vulnerability and medical risk.

“People may not understand what we do,” he said. “But when you think about the woman in front of you, the decision is clear. You are helping someone.”WHO separately announced a webinar linked to the comprehensive abortion care learning programme scheduled for April 28, 2026.

The organization also published updated abortion-related fact sheets in December 2025 as part of its broader reproductive health guidance materials.The HRP programme operates jointly under the United Nations Development Programme, the United Nations Population Fund, the United Nations Children’s Fund, WHO and the World Bank, focusing on research, policy development and training in human reproduction and reproductive health services.

Tedros said he would travel to Tenerife in Spain’s Canary Islands to oversee the disembarkation of passengers, crew members and medical personnel from the Dutch-flagged cruise vessel MV Hondius, which is carrying around 150 people.“I arrived in Spain, where I will join senior government officials in a mission to Tenerife to oversee safe disembarkation,” Tedros said in a post on X.

Three passengers a Dutch couple and a German woman have died after contracting hantavirus during the voyage, while several others have fallen ill, according to health officials.The outbreak has drawn heightened international attention after authorities confirmed infections linked to the Andes virus strain, the only known hantavirus variant capable of transmitting between humans.

Most hantavirus infections are typically spread through contact with infected rodents or their droppings.Tedros said he had remained in direct contact with the ship’s captain, Jan Dobrogowski, and WHO physician Freddy Banza-Mutoka, who is on board the vessel.

“At this stage, there are no additional people on board showing symptoms of hantavirus,” Tedros said, adding that the World Health Organization continued to monitor the situation closely.

He also said the health risk to residents of the Canary Islands and the broader international public remained low.The MV Hondius is expected to dock in Tenerife on Sunday, where Spanish authorities have prepared surveillance and containment measures before arranging special flights to return passengers to their home countries.

Spain’s government said Tedros would meet Prime Minister Pedro Sanchez in Madrid before traveling to the Canary Islands alongside Spain’s health and interior ministers.Spanish ministry officials said the WHO chief would join a command center in Tenerife responsible for coordinating health controls, interagency cooperation and emergency response protocols linked to the ship’s arrival.

The incident has intensified scrutiny over infectious disease preparedness aboard international cruise vessels, particularly involving pathogens with rare but potentially serious transmission characteristics.

A limited hantavirus outbreak linked to an international cruise ship has intensified scrutiny of the United States’ public health preparedness, as scientists and global health officials warn that staffing reductions, laboratory disruptions and political disputes over infectious disease research may undermine responses to future outbreaks.Health experts say the current outbreak remains controllable, with transmission still largely confined to close contacts of infected individuals.

However, the incident has exposed broader concerns about whether public health agencies retain sufficient testing capacity and operational flexibility to respond rapidly if a more dangerous pathogen emerges.According to officials at the World Health Organization, investigators are increasingly focused on evidence suggesting limited human-to-human transmission among individuals who had prolonged close contact with infected patients.

The outbreak has drawn comparisons to a similar hantavirus cluster in Argentina between late 2018 and early 2019, when 34 people tested positive and 11 died. WHO officials said current transmission patterns appear consistent with those earlier cases, including infections involving close family members and healthcare workers.

Maria Van Kerkhove said investigators believe transmission likely occurred between the first infected patients and several close contacts, including a physician who treated patients aboard the cruise ship where the outbreak was first identified.WHO infection prevention specialist Abdirahman Mahamud said aggressive contact tracing, quarantine measures and rapid isolation protocols remain central to containing the outbreak.

He said lessons learned during the Argentina outbreak demonstrated that transmission chains can be interrupted through coordinated public health action.Authorities are now attempting to track passengers from 12 countries, including the United States, who disembarked before the outbreak was identified and later returned home. Epidemiologists said tracing those individuals and anyone they may have contacted while symptomatic remains a critical component of containment efforts.

William Hanage said international coordination may prove more complicated than in previous outbreaks because the passengers dispersed across multiple jurisdictions governed by different public health authorities.Hanage said aggressive contact tracing and quarantine measures would likely be necessary to prevent wider transmission, though he noted that political resistance to such interventions following the Covid-19 pandemic could complicate implementation.

The outbreak is unfolding as US public health infrastructure faces mounting operational and political pressures. Scientists and health officials say laboratory staffing reductions and administrative pauses have already disrupted testing capacity for multiple infectious diseases.According to infectious disease specialist Rochelle Titanji, laboratories responsible for hantavirus testing have experienced staffing cuts, while some federal testing programs have been temporarily suspended.

States currently cannot send samples to the US Centers for Disease Control and Prevention for orthopoxvirus testing, including tests related to mpox, because that division has been paused temporarily, Titanji said. She also noted that federal laboratories can no longer conduct certain diagnostic testing used to determine the specific parasite responsible for leishmaniasis infections.

In April, rabies testing at the CDC was also halted temporarily, according to health officials familiar with the disruptions.At the same time, virology research in the United States has become increasingly politicised. The White House recently issued an executive order restricting certain forms of virus research, while the National Institutes of Health implemented broad funding reductions affecting related scientific work.

US lawmakers have also introduced legislation targeting what they describe as “gain of function” research, a term used in debates surrounding experiments that modify pathogens to study transmissibility or virulence.The debate has intensified amid continuing political disputes over the origins of Covid-19. Although many scientists maintain that available evidence strongly supports zoonotic spillover from animals to humans as the most likely origin of Sars-CoV-2, investigations into possible laboratory-related scenarios continue.

Researchers involved in virology and pandemic studies have increasingly faced subpoenas, investigations and public political scrutiny linked to those debates.Hanage said the current political environment risks weakening scientific preparedness for future outbreaks by discouraging research into zoonotic spillover events.“We should be investing in doing more to understand how these spillover events take place,” he said, adding that current policy trends were moving in the opposite direction.

Public health specialists also expressed concern over legal restrictions adopted in many US states following the Covid-19 pandemic. More than half of US states have enacted laws limiting the authority of public health officials to impose quarantines, recommend masks or enforce certain emergency health measures.Some states have also restricted vaccine requirements for schools and limited the authority of schools to suspend in-person operations during future outbreaks.

Titanji said the relatively limited hantavirus outbreak was already exposing potential weaknesses in outbreak coordination and public compliance. She warned that a more severe pathogen with higher transmission rates or mortality could create substantially greater risks.Despite the United States formally beginning withdrawal procedures from the WHO, the country remains connected to the International Health Regulations framework and continues receiving technical updates and outbreak information from the organisation.

Mahamud said collaboration between WHO officials and US institutions remained active and transparent during the current outbreak response.WHO director-general Tedros Adhanom Ghebreyesus said the outbreak illustrated the continuing importance of international coordination mechanisms during infectious disease emergencies.

He urged both the United States and Argentina to reconsider decisions to leave the WHO, warning that gaps in international cooperation create opportunities for viruses to spread more easily across borders.

The Lebanon Civil Defense said in a statement that one of its rescuers was killed after an Israeli strike targeted him on a road connecting two towns in southern Lebanon.The organization said the attack occurred despite a truce that remains formally in effect between Israel and the Iran-backed militant group Hezbollah.

The incident came one day after another strike killed a rescuer affiliated with the Islamic Health Committee, according to Lebanese authorities.Israel has continued carrying out strikes across parts of Lebanon following weeks of conflict that began on March 2, saying its operations target Hezbollah fighters and military infrastructure.

On May 6, Israeli forces struck Beirut’s southern suburbs for the first time in nearly a month, killing what Israel described as a senior Hezbollah commander from the group’s elite Radwan force.The continuing attacks have intensified concerns among humanitarian agencies over the safety of medical and rescue personnel operating in conflict zones.

Tedros Adhanom Ghebreyesus said earlier this week that the World Health Organization had verified 152 attacks on healthcare facilities and personnel in Lebanon since the conflict began.According to Tedros, those attacks resulted in 103 deaths and 241 injuries.International humanitarian law provides special protections for medical workers, emergency responders and healthcare infrastructure during armed conflicts.

Rights organizations have repeatedly called for investigations into attacks involving rescue and medical personnel in Lebanon and Gaza.

Two World Health Organization collaborating centres in Brazil have played a central role in strengthening efforts to detect and control leprosy and other skin-related neglected tropical diseases across the Americas, contributing technical expertise to the implementation of the Global Leprosy Strategy 2021–2030.

The collaboration involves the Instituto Lauro de Souza Lima and the Fundação Hospitalar Alfredo da Matta, both recognized by WHO for their specialized work in leprosy and dermatological neglected tropical diseases. Their support has focused on improving diagnosis, laboratory confirmation and case management of diseases including leprosy, cutaneous leishmaniasis and sporotrichosis, alongside other dermatological conditions of public health importance.

According to WHO, the two institutions provided highly specialized clinical and laboratory expertise through subregional and national trainings, workshops and dermatological campaigns aimed at strengthening frontline health systems. Physicians, laboratory technicians and other health personnel participated in practical, case-based training designed to improve early detection and diagnostic accuracy.

The centres introduced updated diagnostic algorithms, laboratory protocols and hands-on mentoring during field activities, helping countries improve referral systems between primary care services and specialist centres. WHO said this contributed to earlier detection, shorter diagnostic delays and stronger continuity of care for affected patients.

The work forms part of WHO’s broader Global Leprosy Strategy 2021–2030, which aims to accelerate progress toward zero leprosy, reduce disability caused by delayed diagnosis and interrupt transmission through earlier case identification and stronger surveillance systems.WHO said its own role focused on strategic coordination, ensuring that technical activities aligned with regional and global health frameworks.

The agency used its convening authority to mobilize ministries of health and partners while integrating the work into wider neglected tropical disease and communicable disease elimination strategies.It also oversaw systematic monitoring and documentation to ensure activities remained consistent with WHO standards and reporting mechanisms.

The organization described the arrangement as a combination of normative leadership and operational expertise, allowing field implementation to move beyond policy planning into practical delivery.“The centres’ technical capacity at country level accelerated progress toward elimination targets and strengthened credibility and responsiveness to national requests,” WHO said in its March 27 feature report.

WHO noted that while coordination could have been managed independently, implementation would have been significantly more limited without the specialized expertise of the collaborating centres, and much of the work would have remained theoretical rather than operationally effective.

A major lesson from the programme was the effectiveness of integrated skin screenings, where multiple dermatological conditions are assessed through a single clinical approach rather than disease-specific interventions.WHO said combining screenings for leprosy, cutaneous leishmaniasis, sporotrichosis and other skin-related neglected tropical diseases reduced stigma for patients and improved service uptake, particularly in vulnerable communities where fear of diagnosis often delays treatment.

The approach also strengthened the broader strategy of using skin examination as an entry point for neglected tropical disease control, allowing healthcare workers to identify multiple conditions through a unified platform.Through a series of national and subregional workshops and campaigns, countries across the Region of the Americas were able to reinforce diagnostic capacity and improve laboratory confirmation of suspected cases.

WHO said these activities helped standardize training materials in line with its global guidelines while increasing awareness among frontline workers about integrated management approaches.The collaborating centres also supported the development of stronger regional networks among clinicians and laboratory professionals, helping create a more coordinated technical community across borders.

This regional harmonization was seen as particularly important for countries with limited specialist capacity, where access to standardized protocols and technical cooperation can directly influence case outcomes.The programme’s outcomes align with the broader targets of the WHO Neglected Tropical Disease Road Map, which seeks to reduce the burden of neglected diseases through prevention, early diagnosis and integrated service delivery.

WHO said the collaboration directly supported programme objectives by accelerating early detection and contributing to interruption of transmission, moving countries closer to elimination milestones.Leprosy remains a public health concern in several parts of the Americas despite significant reductions in prevalence over recent decades.

According to WHO’s January 2026 leprosy fact sheet, continued delays in diagnosis remain one of the major barriers to elimination, particularly where health systems lack specialized diagnostic capacity.Cutaneous leishmaniasis and sporotrichosis also continue to present challenges in endemic areas, particularly among vulnerable populations with limited access to specialist dermatological care.

WHO said the collaboration offers further opportunities for expansion, particularly by extending integrated skin neglected tropical disease approaches to additional countries and developing multilingual regional training curricula through digital platforms.

There is also scope to deepen operational research on early detection strategies and strengthen laboratory networks across the region, particularly in underserved settings where diagnosis remains inconsistent.The organization said the experience in Brazil demonstrates how combining global strategy with country-level technical expertise can improve implementation and strengthen health systems beyond individual disease programmes.

By linking specialized dermatological knowledge with WHO’s policy coordination role, the partnership has become a model for how collaborating centres can support disease elimination efforts while building sustainable regional capacity.